INEYE Pharma
Startup focused on the treatment of eye diseases. Technology allows drugs to be administered into the eye for several months in a controlled manner, avoiding the use of drops
INEYE Pharma has raised €100k across 1 funding round from 2 investors, most recently a round in Sep 2023. Based in Portugal; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€100k
€100,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-09
latest 2023-09
Funding by year
EUR raised per yearINEYE Pharma — funding by year — interactive chart.
Data table
| INEYE Pharma — funding by year | |
|---|---|
| 2023 | €100k |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-28 | Other | €100k | Portugal Ventures,Portuguese National Innovation Agency (ANI) | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData